532
Views
23
CrossRef citations to date
0
Altmetric
Original Research

Comparative Effects of Curcumin versus Nano-Curcumin on Insulin Resistance, Serum Levels of Apelin and Lipid Profile in Type 2 Diabetic Rats

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & show all
Pages 2337-2346 | Published online: 03 Jul 2020

References

  • Rines AK, Sharabi K, Tavares CD, et al. Targeting hepatic glucose metabolism in the treatment of type 2 diabetes. Nat Rev Drug Discov. 2016;15(11):786. doi:10.1038/nrd.2016.151
  • Akter S, Rahman MM, Abe SK, et al. Prevalence of diabetes and prediabetes and their risk factors among Bangladeshi adults: a nationwide survey. Bull World Health Organ. 2014;92(3):204–213A. doi:10.2471/BLT.13.128371
  • Guilherme A, Virbasius JV, Puri V, et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9(5):367. doi:10.1038/nrm2391
  • Zhang Z, Bo Y, Tao G-Z. Apelin protects against cardiomyocyte apoptosis induced by glucose deprivation. Chin Med J. 2009;122(19):2360–2365.
  • Kleinz MJ, Davenport A. Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regul Pept. 2004;118(3):119–125. doi:10.1016/j.regpep.2003.11.002
  • Lee DK, Cheng R, Nguyen T, et al. Characterization of apelin, the ligand for the APJ receptor. J Neurochem. 2000;74(1):34–41. doi:10.1046/j.1471-4159.2000.0740034.x
  • Glassford AJ, Yue P, Sheikh AY, et al. HIF-1 regulates hypoxia-and insulin-induced expression of apelin in adipocytes. Am J Physiol Endocrinol Metab. 2007;293(6):E1590–E6. doi:10.1152/ajpendo.00490.2007
  • Sörhede Winzell M, Magnusson C, Ahrén B. The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice. Regul Pept. 2005;131(1):12–17. doi:10.1016/j.regpep.2005.05.004
  • Feng J, Zhao H, Du M, et al. The effect of apelin-13 on pancreatic islet beta cell mass and myocardial fatty acid and glucose metabolism of experimental type 2 diabetic rats. Peptides. 2019;114:1–7. doi:10.1016/j.peptides.2019.03.006
  • Chuengsamarn S, Rattanamongkolgul S, Jirawatnotai S, Phisalaphong C, Jirawatnotai S. Curcumin extract for prevention of type 2 diabetes. Diabetes Care. 2012;35(11):2121–2127. doi:10.2337/dc12-0116
  • Zhang D-W, Fu M, Gao S-H, et al. Curcumin and diabetes: a systematic review. Evid Based Complement Alternat Med. 2013;2013:636053. doi:10.1155/2013/636053
  • Mantzorou M, Pavlidou E, Vasios G, et al. Effects of curcumin consumption on human chronic diseases: a narrative review of the most recent clinical data. Phytother Res. 2018;32(6):957–975. doi:10.1002/ptr.6037
  • Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today. 2012;17(1–2):71–80. doi:10.1016/j.drudis.2011.09.009
  • Cui J, Yu B, Zhao Y, et al. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm. 2009;371(1–2):148–155. doi:10.1016/j.ijpharm.2008.12.009
  • Huang Q, Yu H, Ru Q. Bioavailability and delivery of nutraceuticals using nanotechnology. J Food Sci. 2010;75x(1):R50–R57. doi:10.1111/j.1750-3841.2009.01457.x
  • Ganugula R, Arora M, Jaisamut P, et al. Nano-curcumin safely prevents streptozotocin-induced inflammation and apoptosis in pancreatic beta cells for effective management of type 1 diabetes mellitus. Br J Pharmacol. 2017;174(13):2074–2084. doi:10.1111/bph.13816
  • Ananda PK, Kumarappan CT, Christudas S, et al. Effect of biophytum sensitivum on streptozotocin and nicotinamide-induced diabetic rats. Asian Pac J Trop Biomed. 2012;2(1):31–35. doi:10.1016/S2221-1691(11)60185-8
  • Rajarajeswari N, Pari L. Antioxidant role of coumarin on streptozotocin–nicotinamide‐induced type 2 diabetic rats. J Biochem Mol Toxicol. 2011;25(6):355–361. doi:10.1002/jbt.20395
  • Ghasemi A, Khalifi S, Jedi S. Streptozotocin-nicotinamide-induced rat model of type 2 diabetes (review). Acta Physiol Hung. 2014;101(4):408–420. doi:10.1556/APhysiol.101.2014.4.2
  • Pari L, Srinivasan S. Antihyperglycemic effect of diosmin on hepatic key enzymes of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats. Biomed Pharmacother. 2010;64(7):477–481. doi:10.1016/j.biopha.2010.02.001
  • Mohammadi S, Kayedpoor P, Karimzadeh-Bardei L, Nabiuni M. The effect of curcumin on TNF-α, IL-6 and CRP expression in a model of polycystic ovary syndrome as an inflammation state. J Reprod Infertil. 2017;18(4):352.
  • Faheem NM, El Askary A. Neuroprotective role of curcumin on the hippocampus against the structural and serological alterations of streptozotocin-induced diabetes in sprague Dawley rats. Iran J Basic Med Sci. 2017;20(6):690.
  • Hosseini M, Sedigheh A. Effects of dietary supplementation with ghee, hydrogenated oil, or olive oil on lipid profile and fatty streak formation in rabbits. ARYA Atheroscler. 2012;8(3):119.
  • Soltanmohammadi E, Piran S, Mohammadi A, et al. Serum sdLDL-C and cellular SREBP2-dependent cholesterol levels; is there a challenge on targeting PCSK9. J Med Biochem. 2016;35(4):410–415. doi:10.1515/jomb-2016-0019
  • Ranjbar Kohan N, Nazifi S, Tabandeh MR, et al. Effect of L-carnitine supplementation on apelin and apelin receptor (Apj) expression in cardiac muscle of obese diabetic rats. Cell J. 2018;20(3):427–434. doi:10.22074/cellj.2018.5408
  • Oza MJ, Kulkarni YA. Formononetin treatment in type 2 diabetic rats reduces insulin resistance and hyperglycemia. Front Pharmacol. 2018;9:739. doi:10.3389/fphar.2018.00739
  • Rahimi HR, Mohammadpour AH, Dastani M, et al. The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial. Avicenna J Phytomed. 2016;6(5):567–577.
  • Rahimi HR, Jaafari MR, Mohammadpour AH, et al. Curcumin: reintroduced therapeutic agent from traditional medicine for alcoholic liver disease. Asia Pac J Med Toxicol. 2015;4:25–30.
  • Poolsup N, Suksomboon N, Kurnianta PDM, Deawjaroen K, Atkin SL. Effects of curcumin on glycemic control and lipid profile in prediabetes and type 2 diabetes mellitus: a systematic review and meta-analysis. PLoS One. 2019;14(4):e0215840. doi:10.1371/journal.pone.0215840
  • Palsamy P, Sivakumar S, Subramanian S. Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin–nicotinamide-induced experimental diabetic rats. Chem Biol Interact. 2010;186(2):200–210. doi:10.1016/j.cbi.2010.03.028
  • Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 2001;50(6):537–546.
  • Na LX, Zhang YL, Li Y, et al. Curcumin improves insulin resistance in skeletal muscle of rats. Nutr Metab Cardiovasc Dis. 2011;21(7):526–533. doi:10.1016/j.numecd.2009.11.009
  • Deng YT, Chang TW, Lee MS, et al. Suppression of free fatty acid-induced insulin resistance by phytopolyphenols in C2C12 mouse skeletal muscle cells. J Agric Food Chem. 2012;60(4):1059–1066. doi:10.1021/jf204496f
  • Best L, Elliott AC, Brown PD. Curcumin induces electrical activity in rat pancreatic beta-cells by activating the volume-regulated anion channel. Biochem Pharmacol. 2007;73(11):1768–1775. doi:10.1016/j.bcp.2007.02.006
  • Li Q, Yang Y, Li X, Chen MF, Zheng SS. Study on the acute oral toxicity and genetic toxicity of curcumin. Chin J Health Lab Technol. 2011;21(7):1707–1709.
  • Abdel Rheim F, Ragab AA, Hammam FM, et al. Protective effects of curcumin for oxidative stress and histological alterations induced by pyrethroid insecticide in albino rats. Egypt J Hosp Med. 2015;58(1):63–73. doi:10.12816/0009362
  • Kohli K, Ali J, Ansari MJ, et al. Curcumin: a natural antiinflammatory agent. Indian J Pharmacol. 2005;37(3):141. doi:10.4103/0253-7613.16209
  • Nazari M, Moghimipour E, Tabandeh MR. Betaine down regulates apelin gene expression in cardiac and adipose tissues of insulin resistant diabetic rats fed by high-calorie diet. Int J Pept Res Ther. 2017;23(2):181–190. doi:10.1007/s10989-016-9551-7
  • Li L, Yang G, Li Q, et al. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes. 2006;114(10):544–548. doi:10.1055/s-2006-948309
  • Soriguer F, Garrido-Sanchez L, Garcia-Serrano S, et al. Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obes Surg. 2009;19(11):1574–1580. doi:10.1007/s11695-009-9955-y
  • Yue P, Jin H, Aillaud M, et al. Apelin is necessary for the maintenance of insulin sensitivity. Am J Physiol Endocrinol Metab. 2010;298(1):E59–E67. doi:10.1152/ajpendo.00385.2009
  • Maheshwari RK, Singh AK, Gaddipati J, et al. Multiple biological activities of curcumin: a short review. Life Sci. 2006;78(18):2081–2087. doi:10.1016/j.lfs.2005.12.007
  • Bertrand C, Valet P, Castan-Laurell I. Apelin and energy metabolism. Front Physiol. 2015;6:115. doi:10.3389/fphys.2015.00115
  • Xie X, Tao Q, Zou Y, et al. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms. J Agric Food Chem. 2011;59(17):9280–9289. doi:10.1021/jf202135j
  • Neerati P, Devde R, Gangi AK. Evaluation of the effect of curcumin capsules on glyburide therapy in patients with type-2 diabetes mellitus. Phytother Res. 2014;28(12):1796–1800. doi:10.1002/ptr.5201
  • Ding L, Li J, Song B, et al. Curcumin rescues high fat diet-induced obesity and insulin sensitivity in mice through regulating SREBP pathway. Toxicol Appl Pharmacol. 2016;304:99–109. doi:10.1016/j.taap.2016.05.011
  • Kadoglou NP, Vrabas IS, Kapelouzou A, et al. The impact of aerobic exercise training on novel adipokines, apelin and ghrelin, in patients with type 2 diabetes. Med Sci Monit. 2012;18(5):CR290. doi:10.12659/MSM.882734
  • Kadoglou NP, Fotiadis G, Kapelouzou A, et al. The differential anti‐inflammatory effects of exercise modalities and their association with early carotid atherosclerosis progression in patients with type 2 diabetes. Diabet Med. 2013;30(2):e41–e50. doi:10.1111/dme.12055
  • Dray C, Knauf C, Daviaud D, et al. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab. 2008;8(5):437–445. doi:10.1016/j.cmet.2008.10.003